Chapters

Transcript

Video

What were you trying to learn in the second phase of CAHtalyst? Whether or not you needed super-physiologic doses of glucocorticoids to reduce/maintain androstenedione in combination with upstream CRF1 inhibition mediated by crinecerfont?

What were you trying to learn in the second phase of CAHtalyst? Whether or not you needed super-physiologic doses of glucocorticoids to reduce/maintain androstenedione in combination with upstream CRF1 inhibition mediated by crinecerfont?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Richard Auchus, MD, PhD

Richard Auchus, MD, PhD

Professor of Pharmacology and Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan School of Medicine
Ann Arbor, Michigan